Navidea Biopharmaceuticals NAVB, a biopharmaceutical company
focused on precision diagnostic radiopharmaceuticals, today announced that
data from its Lymphoseek studies in breast cancer and melanoma are being
presented during the month of October at the American Association of
Pharmaceutical Scientists meeting in Chicago, IL, the European Association of
Nuclear Medicine conference in Milan, Italy and the American Society for
Radiation Oncology meeting in Boston, MA. Details of the presentations and
posters are listed below.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in